These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 26311840)

  • 1. Combination of Candida biomarkers in patients receiving empirical antifungal therapy in a Spanish tertiary hospital: a potential role in reducing the duration of treatment.
    Martínez-Jiménez MC; Muñoz P; Valerio M; Vena A; Guinea J; Bouza E
    J Antimicrob Chemother; 2015 Nov; 70(11):3107-15. PubMed ID: 26311840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. β-D-Glucan and Candida albicans germ tube antibody in ICU patients with invasive candidiasis.
    Martín-Mazuelos E; Loza A; Castro C; Macías D; Zakariya I; Saavedra P; Ruiz-Santana S; Marín E; León C
    Intensive Care Med; 2015 Aug; 41(8):1424-32. PubMed ID: 26134359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T2Candida MR as a predictor of outcome in patients with suspected invasive candidiasis starting empirical antifungal treatment: a prospective pilot study.
    Muñoz P; Vena A; Machado M; Gioia F; Martínez-Jiménez MC; Gómez E; Origüen J; Orellana MÁ; López-Medrano F; Fernández-Ruiz M; Merino P; González-Romo F; Frías I; Pérez-Granda MJ; Aguado JM; Fortún J; Bouza E;
    J Antimicrob Chemother; 2018 Mar; 73(suppl_4):iv6-iv12. PubMed ID: 29608751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Candida biomarkers in patients with candidaemia and bacteraemia.
    Martínez-Jiménez MC; Muñoz P; Valerio M; Alonso R; Martos C; Guinea J; Bouza E
    J Antimicrob Chemother; 2015 Aug; 70(8):2354-61. PubMed ID: 25900160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contribution of Candida biomarkers and DNA detection for the diagnosis of invasive candidiasis in ICU patients with severe abdominal conditions.
    León C; Ruiz-Santana S; Saavedra P; Castro C; Loza A; Zakariya I; Úbeda A; Parra M; Macías D; Tomás JI; Rezusta A; Rodríguez A; Gómez F; Martín-Mazuelos E;
    Crit Care; 2016 May; 20(1):149. PubMed ID: 27181045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of β-D-glucan and Candida albicans germ tube antibody for discriminating between Candida colonization and invasive candidiasis in patients with severe abdominal conditions.
    León C; Ruiz-Santana S; Saavedra P; Castro C; Ubeda A; Loza A; Martín-Mazuelos E; Blanco A; Jerez V; Ballús J; Alvarez-Rocha L; Utande-Vázquez A; Fariñas O
    Intensive Care Med; 2012 Aug; 38(8):1315-25. PubMed ID: 22752333
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Performance of Candida albicans germ tube antibodies (CAGTA) and its association with (1 → 3)-β-D-glucan (BDG) for diagnosis of invasive candidiasis (IC).
    Pini P; Colombari B; Marchi E; Castagnoli A; Venturelli C; Sarti M; Blasi E
    Diagn Microbiol Infect Dis; 2019 Jan; 93(1):39-43. PubMed ID: 30098849
    [No Abstract]   [Full Text] [Related]  

  • 8. (1,3)-β-D-glucan-based diagnosis of invasive Candida infection versus culture-based diagnosis in patients with sepsis and with an increased risk of invasive Candida infection (CandiSep): study protocol for a randomized controlled trial.
    Bloos F; Held J; Schlattmann P; Brillinger N; Kurzai O; Cornely OA; Thomas-Rüddel D
    Trials; 2018 Sep; 19(1):472. PubMed ID: 30180873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (1,3)-β-d-Glucan-based antifungal treatment in critically ill adults at high risk of candidaemia: an observational study.
    Posteraro B; Tumbarello M; De Pascale G; Liberto E; Vallecoccia MS; De Carolis E; Di Gravio V; Trecarichi EM; Sanguinetti M; Antonelli M
    J Antimicrob Chemother; 2016 Aug; 71(8):2262-9. PubMed ID: 27125554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Performance of a Quantitative PCR-Based Assay and Beta-d-Glucan Detection for Diagnosis of Invasive Candidiasis in Very-Low-Birth-Weight Preterm Neonatal Patients (CANDINEO Study).
    Ramos JT; Villar S; Bouza E; Bergon-Sendin E; Perez Rivilla A; Collados CT; Andreu M; Reyes CS; Campos-Herrero MI; de Heredia JL; Herrera MCL; Alonso PA; Pallás-Alonso CR; Cuenca-Estrella M;
    J Clin Microbiol; 2017 Sep; 55(9):2752-2764. PubMed ID: 28659321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical factors associated with a Candida albicans Germ Tube Antibody positive test in Intensive Care Unit patients.
    Pemán J; Zaragoza R; Quindós G; Alkorta M; Cuétara MS; Camarena JJ; Ramírez P; Giménez MJ; Martín-Mazuelos E; Linares-Sicilia MJ; Pontón J;
    BMC Infect Dis; 2011 Mar; 11():60. PubMed ID: 21388550
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarker-based strategy for early discontinuation of empirical antifungal treatment in critically ill patients: a randomized controlled trial.
    Rouzé A; Loridant S; Poissy J; Dervaux B; Sendid B; Cornu M; Nseir S;
    Intensive Care Med; 2017 Nov; 43(11):1668-1677. PubMed ID: 28936678
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic surveillance by Candida albicans germ tube antibody in intensive care unit patients.
    Trovato L; Astuto M; Castiglione G; Scalia G; Oliveri S
    J Microbiol Immunol Infect; 2020 Oct; 53(5):778-784. PubMed ID: 30902614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. β-D-glucan surveillance with preemptive anidulafungin for invasive candidiasis in intensive care unit patients: a randomized pilot study.
    Hanson KE; Pfeiffer CD; Lease ED; Balch AH; Zaas AK; Perfect JR; Alexander BD
    PLoS One; 2012; 7(8):e42282. PubMed ID: 22879929
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The diagnostic value of (1,3)-β-D-glucan alone or combined with traditional inflammatory markers in neonatal invasive candidiasis.
    Guo J; Wu Y; Lai W; Lu W; Mu X
    BMC Infect Dis; 2019 Aug; 19(1):716. PubMed ID: 31412796
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biomarkers for the diagnosis of invasive candidiasis in immunocompetent and immunocompromised patients.
    Díez A; Carrano G; Bregón-Villahoz M; Cuétara MS; García-Ruiz JC; Fernandez-de-Larrinoa I; Moragues MD
    Diagn Microbiol Infect Dis; 2021 Nov; 101(3):115509. PubMed ID: 34384954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of ß-D-glucan for diagnosis and follow-up of invasive candidiasis in onco-haematological patients.
    Guitard J; Isnard F; Tabone MD; Antignac M; Brissot E; Senghor Y; Petit A; Leverger G; Hennequin C
    J Infect; 2018 May; 76(5):483-488. PubMed ID: 29432826
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Candida albicans Germ-Tube Antibody: Evaluation of a New Automatic Assay for Diagnosing Invasive Candidiasis in ICU Patients.
    Parra-Sánchez M; Zakariya-Yousef Breval I; Castro Méndez C; García-Rey S; Loza Vazquez A; Úbeda Iglesias A; Macías Guerrero D; Romero Mejías A; León Gil C; Martín-Mazuelos E;
    Mycopathologia; 2017 Aug; 182(7-8):645-652. PubMed ID: 28378240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida Surveillance in Surgical Intensive Care Unit (SICU) in a Tertiary Institution.
    Liew YX; Teo J; Too IA; Ngan CC; Tan AL; Chlebicki MP; Kwa AL; Lee W
    BMC Infect Dis; 2015 Jul; 15():256. PubMed ID: 26137997
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic potential of (1,3)-beta-D-glucan and anti-Candida albicans germ tube antibodies for the diagnosis and therapeutic monitoring of invasive candidiasis in neutropenic adult patients.
    Pazos C; Moragues MD; Quindós G; Pontón J; del Palacio A
    Rev Iberoam Micol; 2006 Dec; 23(4):209-15. PubMed ID: 17388644
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.